first want virtual Good welcome afternoon. earnings Thanks, Oli, our for today. thank and truly to us you you to joining We call.
customers that business. the to confidence Breast drive focus we level. context we'll to steps our our recovery COVID-XX we first our strategy while moving strengthen the on core of and impact and We'll today, the are an results on practice taking discuss helping our including individual provide ahead, call Products the segment, review on are also On pandemic to our on the quarter
financial long for we the flexibility cash are operation ourselves and taking through these to of outline times and the to maintain term. preserve uncertain position levels we'll measures Finally, to necessary
like and that, impacted hearts first I these COVID like are I'd of issues, Before today, discuss many to our pandemic. with those by us say the foremost,
prioritize patients teams, have and of taken our continue steps and safety to and that mitigated. and our risks essential partners to our health the ensure We customers are workers to
credibility are as impact on business, has and constantly these and that in our the will advantages to strategic to increased conditions adapt We we begin ability remain the competitive evolving monitoring to markets and responses changing evaluating and situation our our open. nimble quickly provided already our
said, that a discussion of on With I'll quarter, Sientra decrease recorded sales year-on-year. million, shift results. to our first the X% net a quarter first In $XX.X
Products expander excluding U.S. bioCorneum, over XX% tissue when competitor period gains, which our particularly XX% share equates the demonstrates million, growth. largest revenue our same segment, by implant segment. our year-on-year. XX%. continued reconstruction-related market was Turning This announced and a Breast performance driven exceptional of first Growth net to Sientra quarter sales which $XX.X recorded our first to of strong on year-over-year strong declines during grew breast core at
later we second the and will March record shipments in traction positive his and half will impact impacts the in with quarter began a the of we in COVID-XX of procedures. Paul best-in-class details are and This of QX despite market expander gains call. trend clear revenue. as a has second reduction see provide breast in strong these the segment continued on product seeing quarter more on Products elective relatively a moratoriums result another remarks the is on quarterly Our evidence to Sientra's Breast tissue performance product continued Still, portfolio. experienced share breast growth. our performance,
pandemic COVID-XX consistent the slowdown, before totally said, the this the business. category. Sientra for were remains overall pleased with -- for impact Despite open open we we business began demand to seeing That were
operational. Wisconsin Montana facilities in and manufacturing remain Our
supply We reopen implemented demand a we individual markets continue our also accelerate customers meet which flexible and to to to prepared recovery. our nature changing orders strategy, and practice field are to increasing taking our to adapt are support virtual to measures as commercial product our receive assist to capabilities normalize. begin to customers, customer leverages our infrastructure, of conditions and the to we We've ability ensure that market and their
with aesthetic the of customers. they the To working society to during them following We've they over partnered plastic surgeons not a enable past closely approximately support reopen education, to in this XX% that as But an poll series critical the a and through to Sientra Board facing program on with and to their are training plastic by interested steps: the with of surgeons exclusive communication, reported board-certified host we've taken webinar the new most been weeks, stay some as the serve Sientra has attended certified initiated end, last Sientra connected that this assistance ongoing over the peer-to-peer are which with many we've provide professional conducted of in are X,XXX whom our respondents issues of webinar, current they X practices. crisis.
program. our these of this already team We customers begun engage have sales with to place as plans an in extension directly for
helping for was of staff a new them surgeons valuable for hundreds out rating and Sientra consultations environment. the in practice in management XX% a with programs date, place to we've members our and content that of the one-on-one series XXX% have to recovery. has To plans and webinars also of succeed trained loyal ensure sponsored plan in they with customers practice providing that
important the which of site most the have we practices needs and a adapting how through prepare professional contains help tools COVID into exist and I to already reentry the today. to visit market. that our encourage new to to to better quickly support website, launched We all online you drivetherecovery.com, this this drive are pandemic to understand them
patient consultations in virtual drive Sientra has offices. awareness our to also and acquisition physician launched pilot its digital create patient
the While promising, early, have results very been promising.
seeing interest will consultations remains individual patient intends start our the reopen. additional book to the and belief pilot materialize extend within virtual as accounts year. that are the We into days balance practices surgeries strong Sientra through to date, patients reinforces of of the which
initial placements, we the in Although early some implementation with the stages of continue of account we we'll to we learn. results of beginning order see are these adapt already to conversions initiatives, and are as and
surgeons the Our forefront consultants surgeries strategy. this employ They're expert extensive customer sales rebound. initiatives our remains their of practices these training plastic in team as help completing of and rebuild to engagement to surgery
well occurring are supporting proven that our engagement regions, we we these new higher premium profitability customers patient As promotions recovery practice our sales in several management strategies, back procedures with which accelerated on products. increasingly practice see patient come online, and as as drive already tools
from priorities believe customers' to advantaged We compared that our our continued through to period. plastic be programs best-in-class relationship-building our consultants adapting market and ability quickly of this drive to competitively our confidence support surgery forward. our real-time marketing and share competitors, going success The recovery to expect efforts larger we our to are historical in
to procedures. said, U.S. impacted breast that expect the second be surgical elective customers restrictions initiatives The marketing cancellation We grow second our by believe in the of relax and across results heavily of coming the these states we for our Sientra product quarter, to the quarter expected to are beginning With we expect surgeries, on well has into and weeks. will decrease and position continued the a states return. procedures list in
business restrictions of be phase our -- to implant portfolio, market from recovery, our other and beyond to as and expect XXXX benefit we superiority in as these the on less may procedures. with nature lifted. prioritize our earliest demand elements reconstruction bolus through are will portfolio to of innovative continue of as AlloxX outperform We we We the reconstruction from procedures a business, clinical well the as continue pent-up which and reconstruction elective believe of benefit our expander
U&A, We're in Japan. also our expect approval this obtain in Japanese association agency. the an and agreement devices international products approval best-in-class year. with of select announce are half the in the signing time Medical second to application pharmaceutical of lines into with beginning for to U&A a Medical And the And breast during although of with approval with markets distribution hard we first quarter, predict, filed we excited the medical of expansion to
Turning the to first sales of the COVID-XX. of in to $X.X majority from share We year-over-year decline. sales come have million the during our sales, The in was in Pacific which quarter. month region, U.S. XX% of U.S. miraDry the in impact bulk COVID-XX miraDry that concentrated the approximately the and which Historically, U.S. the believe primarily crisis the came U.S. in console with outside by attributable Asia half weeks which of quarter, earlier any impacting decline was equates quarter our the the of a segment. in than occur achieved markets. of We impacted much of the to typically of timing remaining the quarter, final the the given final
the the materially such impacted value capital that As result on anticipate industry on investments. high pull aesthetic be COVID-XX, as sales dollar we XXXX will of equipment impact throughout accounts back
success have that The our miraDry segment. on we refocused shift those to the customers they the By driving ensure patients effective and strategy continue this accounts, most in customer their company that awareness concentrating attract market, drive on to that generating bioTip revenue existing recognition will proven been changing In order to high-margin stream. they in our business our miraDry support existing to existing grow of growth to we've will funneling can patients programs have to base.
impact with of are United structure. placements, recurring in of large quarter, rich XXX the and opportunity Leading X,XXX seeing COVID-XX, we to approximately global high-margin console plastic drive strong utilization up were commercial revenue more our cost-effective accounts we surgery initial the the with primarily in to States, first which in a over have growth
the measures we patient We global connection more force to teams highly quarter. this reorganizing the term. The create consultants will made operation business generation focus, creating the we enable will a result cost-efficient that that with initiative, discussed organizational headcount efficiency simpler company and a addition of value fourth long confident its is reduction This remain of these to in drive to miraDry over headcount, streamlined miraDry with in in and motivated to accounts. create our align reduction to sales which us in
that, impact Paul. financial actions of remarks. the to it discuss will With in turn these his I'll Paul over
